Wockhardt logo

Wockhardt share news, announcements and annual reports

NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap

Wockhardt Limited · Face value ₹5 · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15

Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.

2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10

52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
Market cap
₹30,817 Cr311th largest listed
P/E
75.16
P/B
5.97
Dividend yield
Nonein the last 12 months
ROE
8.4%
ROCE
7.0%
Debt to equity
0.39
Volume, NSE
6,06,59351.5% delivered

Wockhardt share news and announcements

1,014 announcements, routine notices left out, newest first. Page 18 of 21.

  1. May 2010

    • 20 May · Results

      Standalone Results for the period ended on 31-MAR-2010 as follows: Net Sales of Rs. 186851 lacs for period ending on 31-MAR-2010. Net Profit / (Loss) of Rs. (79421) lacs for the period ending on 31-MAR-2010.
    • 20 May · Results

      Consolidated Results for the period ended on 31-MAR-2010 as follows: Net Sales of Rs. 450142 lacs for period ending on 31-MAR-2010. Net Profit / (Loss) of Rs. (100065) lacs for the period ending on 31-MAR-2010.
    • 20 May · Results

      Standalone Results for the period ended on 31-MAR-2010 as follows: Net Sales of Rs. 38203 lacs for period ending on 31-MAR-2010. Net Profit / (Loss) of Rs. (29426) lacs for the period ending on 31-MAR-2010.
    • 20 May · Results

      Consolidated Results for the period ended on 31-MAR-2010 as follows: Net Sales of Rs. 87198 lacs for period ending on 31-MAR-2010. Net Profit / (Loss) of Rs. (56510) lacs for the period ending on 31-MAR-2010.
    • 5 May · Board meeting

      Inter alia, to transact the following business : (i) To consider and approve the audited Financial Accounts of the Company for a period of fifteen months ended March 31, 2010 ("Financial Year"). (ii) To consider and approve the audited Financial Results of the Company for the quarter and a period of fifteen months ended March 31, 2010 ("Financial Year").
  2. Apr 2010

    • 28 Apr · Business

      Press release dated April 28, 2010, titled "Wockhardt launches Prostate drug Flomax in the United States on Day-1". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 15 Apr · Results

      Company will submit Audited Financial Results for the Financial Year January 01, 2009 to March 31, 2010 on or before May 30, 2010 and hence the unaudited financial results for the last quarter ended March 31, 2010 will not be submitted to the Exchange.
    • 1 Apr · Allotment of preference shares

      Pursuant to the approval of members obtained by way of postal ballot on December 24, 2009 and in terms of CDR approved package, the Company has allotted 839,903,029 Non- Convertible Redeemable Preference Shares of Rs.5/- each and 392,838,529 Optionally Convertible Cumulative Redeemable Preferences Shares of Rs.5/- each. The details of allotment of Optionally Convertible Cumulative Redeemable Preference Shares shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 1 Apr · Management

      Mr. Rajiv B. Gandhi has resigned from the position of Whole-Time Director and Company Secretary w.e.f. March 31, 2010 and Mr. Jayantt Manmadkar has been appointed as Company Secretary w.e.f. March 31, 2010. Further, Mr. Vijay Khetan continues to act as Compliance Officer of the Company
    • 1 Apr · Business

      Press release dated April 01, 2010, titled "Wockhardt and Abbott jointly terminate the Nutrition business deal". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  3. Feb 2010

    • 16 Feb · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  4. Jan 2010

    • 25 Jan · Management

      At the meeting of Board of Directors of the Company held on January 25, 2010, the Board approved re-appointment of Mr. H. F. Khorakiwala, Chairman for a period of five years w.e.f March 01, 2010 subject to the approval of members in general meeting.
    • 25 Jan · Results

      Standalone Results for the period ended on 31-DEC-2009 as follows: Net Sales of Rs. 39544 lacs for period ending on 31-DEC-2009. Net Profit / (Loss) of Rs. (15996) lacs for the period ending on 31-DEC-2009.
    • 25 Jan · Results

      Consolidated Results for the period ended on 31-DEC-2009 as follows: Net Sales of Rs. 88933 lacs for period ending on 31-DEC-2009. Net Profit / (Loss) of Rs. (18123) lacs for the period ending on 31-DEC-2009.
    • 14 Jan · Board meeting

      Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and twelve months ended December 31, 2009.
    • 13 Jan · Business

      Press release dated January 13, 2010, titled "Wockhardt receives US FDA approval for antibacterial Levofloxacin". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 6 Jan · Business

      Press release dated January 06, 2010, titled "Wockhardt receives US FDA approval for Alzheimer's drug Memantine". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  5. Dec 2009

    • 28 Dec · Results

      Result of Postal Ballot on the Resolution as proposed in the Notice dated November 18, 2009, the results were declared by the Chairman on December 24, 2009. A copy of the result of postal ballot shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 2 Dec · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  6. Nov 2009

    • 25 Nov · Meeting

      Notice of Postal Ballot pursuant to Section 192A of the Companies Act, 1956 for passing the following resolutions under section 16, 94, 31, 80, 81 (1A) of the Companies Act, 1956 through postal ballot : 1) Increase in Authorised Share Capital of the Company from Rs.175 crores to Rs.925 crores and alteration of clause V of Memorandum of Association of the Company. 2) Alteration of Article 4 of the Articles of Association of the Company. 3) Preferential issue of not more than 160 crores Convertible and/or Non-Convertible Redeemable Preference shares of Rs.5/- each. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 18 Nov · Increase in authorised share capital/others

      The Board of Directors of the Company at its meeting held today i.e. on November 18, 2009, considered the following matters: (1) Increase in Authorised share capital of the Company from Rs.175 Crores to Rs.925 Crores by creation of 150 crores preference shares of Rs.5/- each and consequential alterations of Memorandum and Articles of Association of the Company. (2) Preferential Issue upto 160 crore Convertible/ Non-convertible redeemable preference shares of Rs.5/- each. (3) Approval of postal ballot notice along with the postal ballot form and calendar of events for obtaining consent of the members of the Company on aforesaid matters through postal ballot
    • 18 Nov · Business

      Press release dated November 18, 2009, titled "Wockhardt launches anti-hypertensive drug Nicardipine injections in USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  7. Oct 2009

    • 31 Oct · Results

      Consolidated Results for the period ended on 30-SEP-2009 as follows: Net Sales of Rs. 92269 lacs for period ending on 30-SEP-2009 against Rs. 92348 lacs for the period ending on 30-SEP-2008. Net Profit / (Loss) of Rs. (5420) lacs for the period ending on 30-SEP-2009 against Rs. 6219 lacs for the period ending on 30-SEP-2008.
    • 31 Oct · Results

      Standalone Results for the period ended on 30-SEP-2009 as follows: Net Sales of Rs. 38330 lacs for period ending on 30-SEP-2009 against Rs. 41683 lacs for the period ending on 30-SEP-2008. Net Profit / (Loss) of Rs. (5909) lacs for the period ending on 30-SEP-2009 against Rs. 1343 lacs for the period ending on 30-SEP-2008.
    • 16 Oct · Board meeting

      Inter alia, to consider and approve the unaudited financial results for the quarter and nine months ended September 30, 2009.
    • 1 Oct · Business

      Press release dated October 01, 2009, titled "Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  8. Sep 2009

    • 29 Sep · Business

      Press release dated September 29, 2009, titled "Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 24 Sep · Business

      Press release dated September 24, 2009, titled "Wockhardt wins Government of India Patent Award; 70 Patents Granted: 15 Indian and 55 International". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 11 Sep · Results

      Result of Postal Ballot on the Ordinary Resolution as proposed in the Notice dated July 27, 2009. Further, the Ordinary Resolution pursuant to Section 293(1)(a) to transfer, sell and/ or dispose of the Mother and Child Care Business and Nutriuno business of the Company to Abbott Healthcare Private Limited, India, has been passed with requisite majority. A copy of Result of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 3 Sep · Limited Review Report

      Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  9. Aug 2009

    • 20 Aug · Business

      Press release dated August 20, 2009, titled "Wockhardt divests its Veterinary business to Vetoquinol". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 12 Aug · Meeting

      Notice of Postal Ballot pursuant to Section 192A of the Companies Act, 1956 for passing an Ordinary Resolution u/s 293(1)(a) of the Companies Act, 1956 through Postal Ballot Process for transferring, selling and/or disposing of the Mother and Child Care Business and Nutriuno Business of the Company to Abbott Healthcare Private Limited, India . A copy of the postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 7 Aug · Results

      Result of Postal Ballot on the Ordinary Resolution as proposed in the Notice dated June 29, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 3 Aug · Extension of Financial Year

      At the meeting of Board of Directors at its meeting held on July 30, 2009 has decided that the Financial Year of the Company ending on December 31, 2009 be extended for a further period of three months to close on March 31, 2010 and shall close on that date every subsequent year thereafter so that the balance sheet and profit and loss account giving effect to such extension shall be prepared for a period of fifteen months from January 01, 2009 to March 31, 2010.
  10. Jul 2009

    • 30 Jul · Results

      Standalone Results for the half year ended on 30-JUN-2009 as follows: Net Sales of Rs. 70773 lacs for half year ending on 30-JUN-2009 against Rs. 71674 lacs for the half year ending on 30-JUN-2008. Net Profit / (Loss) of Rs. (28103) lacs for the half year ending on 30-JUN-2009 against Rs. 2412 lacs for the half year ending on 30-JUN-2008.
    • 30 Jul · Results

      Consolidated Results for the half year ended on 30-JUN-2009 as follows: Net Sales of Rs. 181742 lacs for half year ending on 30-JUN-2009 against Rs. 172074 lacs for the half year ending on 30-JUN-2008. Net Profit / (Loss) of Rs. (20011) lacs for the half year ending on 30-JUN-2009 against Rs. 15670 lacs for the half year ending on 30-JUN-2008.
    • 30 Jul · Results

      Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 36673 lacs for quarter ending on 30-JUN-2009 against Rs. 38708 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. (26059) lacs for the quarter ending on 30-JUN-2009 against Rs. 2335 lacs for the quarter ending on 30-JUN-2008.
    • 30 Jul · Results

      Consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 95415 lacs for quarter ending on 30-JUN-2009 against Rs. 93503 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. (18987) lacs for the quarter ending on 30-JUN-2009 against Rs. 10587 lacs for the quarter ending on 30-JUN-2008.
    • 29 Jul · Updates

      Board of Directors of the Company have approved the notice of postal ballot along with the postal ballot form and calendar of events for obtaining consent of the members of the Company for sale / transfer / disposal of Mother and Child Care Business and Nutriuno business of the Company as a slump sale on going concern basis at such price and on such terms and conditions as may be decided by the board.
    • 28 Jul · Business

      Press release dated July 28, 2009, titled "Wockhardt signs agreements to divest its Nutrition businesses to Abbott". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 20 Jul · Board meeting

      Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended June 30, 2009.
    • 9 Jul · Updates

      The Corporate Debt Restructuring Package for the Company has been approved by the CDR Empowered Group on 30th June 2009. The Company has accepted the CDR package and greatly acknowledges the support extended by all the lenders in the restructuring process. Restructuring of debt, release of working capital and fresh priority debt by banks pending divestment of non-core assets is a positive step forward and shall provide a great impetus to the core operations of the Company
    • 7 Jul · Meeting

      Notice of Postal Ballot pursuant to Section 192A of the Companies Act, 1956 for passing an Ordinary Resolution u/s 293(1)(a) of the Companies Act, 1956 through Postal Ballot Process for transferring, selling and/or disposing of the Animal Healthcare Business of the Company to a wholly owned (direct or indirect) subsidiary of Vetoquinol S.A, France. A copy of the postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  11. Jun 2009

    • 30 Jun · Meeting

      Outcome of the Annual General Meeting held on June 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 29 Jun · Business

      Press release dated June 27, 2009, titled "Wockhardt signs agreement to divest its Animal Health Division". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 17 Jun · Divestment

      Company has divested its German business Esparma to Mova GmbH, a subsidiary of Lindopharm GmbH, Germany. Wockhardt had acquired the Esparma business in May 2004. Wockhardt continues to be on the growth track and this initiative is the first step towards its on-going strategy to re-structure, rationalise and optimise all of its business and raise fresh capital by divesting some of its smaller operations and non-core businesses. Wockhardt is re-inventing itself by taking fundamentally strong and positive steps.
    • 2 Jun · Results

      Result of Postal Ballot on the Ordinary Resolution as proposed in the Notice dated April 24, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 1 Jun · Updates

      Notice u/s 640B of the Companies Act, 1956 intending to make an application to the Central Government for matters relating to managerial remunerations which is published in the newspaper May 19, 2009.The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.